Oncotarget A New Method of Targeting Exosomes in Precision Medicine Oncotarget published a new editorial perspective by Dr. Mujib Ullah, entitled, "The future of bioorthogonal-chemistry... read more December 20, 2022
Oncotarget Plasma Growth Hormone in HCC: A Biomarker of Response to Atezo/Bev? In a new study, researchers investigated the plasma growth hormone as a potential biomarker of... read more December 8, 2022
Oncotarget Biomarkers May Predict Neoadjuvant Chemosensitivity in Bladder Cancer In a new study, researchers aimed to identify and validate predictive biomarkers of response to... read more November 15, 2022
Oncotarget New Target Fights Ferroptosis- and Radio-Resistance in Lung Cancers Researchers published a research perspective about a recent study that uncovered FSP1 as a novel... read more November 2, 2022
Oncotarget Synergy of HDACi, PARPi and Chemotherapeutics Against Blood Cancer Researchers investigated the efficacy of HDAC inhibitors in combination with PARP inhibitors and chemotherapeutic drugs... read more October 19, 2022
Oncotarget CRISPR Screens Identify Novel Targets for Personalized Cancer Therapy In this trending new study, researchers used CRISPR-based genome-wide screens to identify genetic determinants of... read more October 7, 2022
Oncotarget How High Altitudes Influence HIF-1, Gastric Cancer & Patient Survival In a new study, researchers evaluated the high altitude in Ecuador and how it may... read more September 27, 2022
Oncotarget Protein-Based Risk Model Predicts Esophageal Cancer Recurrence Researchers developed a multi-protein expression-based risk model to predict recurrence-free survival for ESCC patients.The... read more September 23, 2022
Oncotarget Immunotherapy Response Predicted by Machine Learning & Gut Microbiomes Researchers investigated common gut microbiome features of response among immunotherapy patients with different advanced-stage cancers.... read more September 1, 2022
Oncotarget Epigenetics and Immunotherapy Combined Fights Rare Lymphoma In a new Oncotarget study, researchers assessed an epigenetic and immunotherapy treatment regimen among patients... read more August 24, 2022